Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China.
Laboratory of Cancer Epigenetics, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Cancer Med. 2023 Feb;12(3):3185-3200. doi: 10.1002/cam4.5077. Epub 2022 Jul 31.
MicroRNAs (miRNAs) are a class of non-coding single-stranded RNA molecules with a length of approximately 18-25 nt nucleotides that regulate gene expression post-transcriptionally. MiR-204-5p originates from the sixth intron of the transient receptor potential cation channel subfamily M member 3 (TRPM3) gene. MiR-204-5p is frequently downregulated in various cancer types and is related to the clinicopathological characteristics and prognosis of cancer patients. So far, many studies have determined that miR-204-5p functions as a tumor suppressor for its extensive and powerful capacity to inhibit tumor proliferation, metastasis, autophagy, and chemoresistance in multiple cancer types. MiR-204-5p appears to be a promising prognostic biomarker and a therapeutic target for human cancers. This review summarized the latest advances on the role of miR-204-5p in human cancers.
微小 RNA(miRNAs)是一类约 18-25nt 核苷酸长的非编码单链 RNA 分子,通过转录后调控基因表达。miR-204-5p 来源于瞬时受体电位阳离子通道亚家族 M 成员 3(TRPM3)基因的第六内含子。miR-204-5p 在多种癌症类型中经常下调,与癌症患者的临床病理特征和预后相关。到目前为止,许多研究已经确定 miR-204-5p 作为肿瘤抑制因子发挥作用,因为它具有广泛而强大的能力,可以抑制多种癌症类型中的肿瘤增殖、转移、自噬和化疗耐药性。miR-204-5p 似乎是一种很有前途的预后生物标志物和人类癌症的治疗靶点。本综述总结了 miR-204-5p 在人类癌症中的最新研究进展。